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An antigen that is present on the cells from many patients with acute lymphoblastic 
leukemia  (ALL) and some patients with chronic myelocytic leukemia  (CML) in blast 
crisis  (1-6)  has  been  called  the  common ALL antigen  (CALLA). The  antigen  was 
initially serologically defined by Greaves (1), and, by immunoprecipitation with xeno- 
antisera, the antigen was reported to be a  95,000-100,000 mol wt glycoprotein (4,  7). 
More recently (8), a  monoelonal antibody (J-5) was generated to CALLA by Ritz et. 
al.  The  murine  monoelonal  antibody  also  precipitated  a  95,000-100,000  mol  wt 
antigen  that  demonstrated  identical  serological  specificity  to  the  xenoantisera  of 
Greaves when  tested on uncultured  cells from leukemic patients  (8,  9).  There were, 
however, some reported  specificity differences between  the J-5  monoclonal and  the 
various polyclonal antisera in the detection of CALLA on marrow cells ofnonleukemic 
patients  and  on  T-ALL cells  and  cell  lines.  The J-5  monoclonal  antibody  usually 
failed to react with bone marrow cells from normal donors, cells from T-ALL patients, 
or with T-ALL cell  lines  (8), whereas  the polyclonal xenoantisera  in some instances 
showed some degree of cross-reactivity with these cell types (3-5, 10-12). However, no 
other  cells  or  tissues  tested  had  detectable  levels  of CALLA,  and  thus  the  J-5 
monoclonal reagent  had apparent  value as a  diagnostic reagent,  and more recently 
(13)  it  has  been  used  in  passive  serotherapeutic  studies.  This  report  describes  the 
detection of CALLA on certain cell types of nonhematopoietic adult and fetal tissues, 
as determined by immunoperoxidase staining with the J-5 monoclonal antibody. Our 
study indicates that this antigen is unlikely to be a true differentiation antigen specific 
for lymphoid cells. 
Materials  and Methods 
Monoclonal Antibody.  The J-5 monoclonal antibodies were graciously provided as aseitic fluid 
by Dr. Jerome Ritz of the Sidney Farber Cancer Institute,  Boston, Mass. The J-5 antibodies 
have been routinely used in our laboratory for membrane phenotyping of marrow, blood, or 
lymphoid tissue  cells from patients with leukemia and lymphoma by cytotoxicity and immu- 
nofluorescenee (14). Control ascites fluid was obtained from BALB/c mice injected intraperi- 
tonealy with the P3 ×  63Ag 8 myeloma cell line (P3). 
Collection of Tissue.  Portions of various normal tissues  were removed during the course of 
surgery  and  processed  within  2  h  of their  removal.  In addition,  a  20-wk-old  fetus  from  a 
prostaglandin-induced  abortion  was obtained  ~6  h  after  delivery,  and  a  full  autopsy was 
performed. Portions of most tissues were reserved to be processed, as described below. 
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Tissue Processing.  Tissue was cut into 2- to 4-mm  2 pieces and embedded in blocks containing 
a solution of 7.5% gelatin. The blocks were snap-frozen by submersion in isopentane that had 
been precooled in liquid nitrogen and were stored at -70°(2. Sections were cut at a  thickness 
of .5-7 #m on a microtome-cryostat, thaw-mounted onto gelatin-coated slides, and immediately 
fixed in acetone at -20°(3 for 15-30 sec. Slides were either stored at -70°(2 or used immediately 
for immunoperoxidase staining. 
Immunoperoxidase Testing.  Sections were stained using a modified indirect immunoperoxidase 
procedure (15).  After preincubation of the tissue sections with  10% nonimmune goat serum, 
they were incubated for 60 min at room temperature with 1:1000 diluted J-5 or P3 ascitic fluid. 
A  second 45  min  incubation was performed with a  1:50  dilution of horseradish peroxidase- 
conjugated goat anti-mouse IgG (N.  L. (2appel Laboratories, Inc., (2ochranville, Pa.). Slides 
were developed by incubation for 15 min with a solution of diaminobenzidine (0.5 mg/ml) and 
hydrogen peroxide (0.001%)  in 0.05  M  Tris buffer at  pH  7.6 and were counterstained with 
hematoxylin. 
Preparation of Kidney Membrane Glycoproteins.  A  segment of normal kidney containing both 
medulla and cortex was cut into small fragments, and cells were gently teased from the organ 
using 20-gauge needles. The cells were washed, and crude membrane fragments were prepared 
by  hypotonic  lysis and  density gradient  centrifugation,  as  previously described  (16).  The 
membrane  fragments were solubilized for  15  min  at  4°(2  in  2  ml  of 0.5%  (wt/vol) sodium 
deoxycholate (DO(2) in 0.1 M  borate buffer, pH 8.5, and centrifuged for 60 min at  100,000 g. 
The protein content of the supernate was estimated by reading absorbance at 280 and 260 nm, 
and  100 #g of supernate was labeled by the lactoperoxidase method of (2ollins et al. (17). 
1 ml  of the  l~SI-labeled kidney antigen  was  preabsorbed  for  15  min  at  23 °  with  0.2  g 
formalin-fixed Staphylococcus aureus (Pansorbin; (2albiochem-Behring Corp., American Hoechst 
Corp., La Jolla, Calif.). An aliquot of this preabsorbed antigen was added to 100 #1 of packed 
Pisum sativum lectin bound to Sepharose 4B, incubated 30 min at 23 °, and washed 5 times with 
10  ml of Tris-DOC buffer.  The  lectin-bound material was  then  eluted with 0.5  ml of 10% 
glucose in Tris-DO(2 buffer. The P. sativum lectin beads were a  generous gift of Dr.  R. Byrn 
(Duke University, Durham, N. (2.). 
Immunoprecipitation  and  Sodium  Dodecyl  Sulfate-Polyac(ylamide  Gel  Electrophoresis  (SDS- 
PAGE).  Aliquots of S. aureus preabsorbed, lectin-bound kidney antigen were precipitated with 
J-5 and P3 ascites by previously described methods (18). The common ALL-derived cell line, 
697, which we had previously shown to express CALLA, was radioiodinated with lactoperoxi- 
dase (17) and used as a positive control. The 697 cell line was kindly provided by Dr. A. Ragab 
(Emory University, Atlanta, Ga.). 
Results 
Sections of various tissues from  a  20-wk-old fetus  and  from  a  number  of normal 
adults were  tested with  the J-5  ascitic fluid. The  following tissues demonstrated no 
significant immunohistochemical staining when  compared to the P3  ascites control: 
fetal  heart,  liver,  lung,  pancreas,  salivary  gland,  spleen,  and  thymus;  and  adult 
skeletal muscle, spleen, tonsil, salivary gland, small intestine, and colon. Certain adult 
and fetal tissues, however, showed significant staining. In the adult kidney, most but 
not all of the tubules stained intensely (Fig. 1). The large number of postively staining 
tubules and their lower nuclear density compared to the nonstaining tubules indicate 
that the CALLA-positive cells are in the proximal tubules. The pattern of staining in 
the tubules was apical, and sloughed or secreted antigenic material was present in the 
tubular  lumens.  In  addition to  the  tubular  staining,  there  was  intense  glomerular 
staining in a  fairly linear pattern along glomerular basement membranes.  A  similar 
staining pattern was present  in  fetal kidney. Again, some but  not all of the tubules 
stained, and there was intense staining of the cells forming the primative glomeruli. 
The fetal small intestine also showed apical staining of the epithelial cells of the villi 
(Fig.  2),  and  occasionally some  shedding  of antigenic  material was  noted,  but  no 
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Fla.  1.  Frozen section of normal kidney stained by immunoperoxidase with antibody  J-5 (A) and 
with P3 ascites control (B). There is intense staining for J-5 in glomeruli (G) and on the surface and 
within the lumens of proximal tubules (P). Distal tubules (D) do not stain. The continuity between 
proximal tubules  and  glomerular epithelium is fortuitously  illustrated in  this  section  (arrow). 
Hematoxylin counterstain,  X 250. 
Fro.  2.  Frozen section of fetal small intestine stained by immunoperoxidase with antibody  J-5 (A) 
and with P3 ascites control (B). Several villi are shown cut in cross section, and the bowel lumen is 
represented by the empty space between villi. There is an intense rim of staining by J-5 along the 
lumenal border. Hematoxylin counterstain,  × 250. 
In contrast, a  different pattern of staining was noted in the adult breast. Although 
there  was  no  significant  staining  of the  breast  epithelium  or  the  material  within 
glandular lumens, there was staining around the myoepithelial cell layer of the breast 
(Fig. 3). This was particularly prominent around the breast ductal cells but was also 
seen  to some extent  around  the  acini of the breast.  Interestingly, the  myoepithelial 
cells of the salivary gland did not stain. 
The J-5 ascites immunoprecipitated a  molecule with an apparent ~90,000  mol wt 
from  a  lactoperoxidase-labeled kidney membrane  glycoprotein preparation  (Fig. 4, 
lane  b).  The  molecule  precipitated  from  the  kidney  migrated  faster  than  that 
precipitated from the 697 cell line (Fig. 4, lane a). 1252  METZGAR  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Fro.  3.  Frozen section of  normal breast stained by immunoperoxidase with antibody J-5. A ductule 
is cut in cross section illustrating central, nonstaining epithelial cells surrounded by a myoepithelial 
rim that is heavily stained (arrows). The myoepithellal cells are in turn well demarcated from the 
surrounding nonstaining stroma. Hematoxylin counterstain, ×  680. 
Fro.  4.  Immunoprecipitates of lactoperoxidase-labeled kidney membrane glycoproteins analyzed 
on  SDS-PAGE.  Immunoprecipitates  were  electrophoresed on  10%  polyacrylamide  gels  under 
reducing conditions. The lactoperoxidase-labeled common ALL-derived cell line, 697, was precipi- 
tated with J-5 ascites (A). Kidney membrane glycoproteins were precipitated with J-5  (B)  or P3 
ascites (C). Arrows indicate the position of mol wt markers. 
Discussion 
The  common  ALL  (CALLA)  antigen  was  originally  described  (10,  11)  as  a 
leukemia-associated antigen, and  the antigen defined by the xenogeneic polyclonal 
antisera was subsequently reported to be on a very small percentage of fetal liver and 
normal bone marrow lymphoid cells. However, this cross-reactivity was not unequiv- 
ocally  demonstrated  with  the  J-5  monoclonal  (8,  9).  Thus,  the  idea  of treating 
common  ALL patients  with  the J-5  antibody seemed  very attractive.  This  report 
demonstrates that the J-5 antigen is not restricted to common ALL cells but is also 
present on several nonhematopoietic tissues. In particular, it is present on proximal 
tubules and glomeruli of the kidney. Because the epithelial cells of the glomeruli are 
continuous with the proximal tubule, it is possible that the glomerular staining is on 
the podocyte and not the basement membrane. It is interesting that another common 
ALL antigen, P24  (19), as recognized by the monoclonal antibody DU-ALL-1  (20), 
is also present on kidney. However, in contrast to the antigen detected by the J-5- 
monoclonal, the P24 antigen  is  present  on distal  tubules  and  collecting ducts to a 
greater extent than on proximal tubules (unpublished data). The J-5 antigen is on the 
apical  portion  of the  renal  tubules  and  is  in  a  similar  location  in  the  fetal  small 
intestine,  suggesting  that  CALLA  may  in  some  way  be  related  to  microvillial 
absorption. CALLA, however, was not detected in other glandular surfaces but was 
demonstrated on myoepithelial ceils of the breast. Because J-5-reactive material was 
present  in  the  lumen  of the  kidney tubules  and  along  the  microvilli  of the  fetal 
intestine,  it  seems that  the antigen  is shed  in  vivo, and  this  is consistent with  the 
observation that CALLA is readily shed in vitro (7). The antigen was not detected on 
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portions of fetal and adult small bowel has not yet been completed. The function of 
CALLA is not yet evident from its tissue distribution. 
The presence of a J-5-reactive molecule in kidney was confirmed by the immuno- 
precipitation of a  molecule with an apparent ~90,000  mol wt from lactoperoxidase- 
labeled kidney membrane glycoproteins. The difference in migration of the antigen 
band from renal cells vs. that from the CALLA-positive cell line 697 could represent 
a true difference in polypeptide or carbohydrate composition of the molecule bearing 
the J-5-reactive determinant, or it could be due to the degradation of the molecule by 
the action of proteases or glycosidases during the processing and labeling of the renal 
cells. The treatment  of Nalm-1  antigens with glycosidases or tunicamycin has been 
shown (9) to reduce the apparent mol wt of the CALLA molecule. Further biochemical 
and immunochemical analyses of kidney, common ALL cells, and other J-5 antigen- 
positive  tissues  are  required  to  determine  the  structura!  relationship  of these j-5- 
reactive molecules. 
The detection  of CALLA on some epithelial cells of kidney, breast, and intestine 
suggests that treatment of common ALL patients with the J-5 monoclonal antibody 
should  be  done  with  caution.  Although  the  hematological  toxicity  is  likely  to  be 
minimal because of the extremely restricted hematopoietic distribution of CALLA, it 
is important to evaluate patients receiving this therapy for renal and gastrointestinal 
toxicity. 
Summary 
The common acute lymphoblastic leukemia antigen  (CALLA), as defined by J-5 
murine monoclonal antibodies, was detected on renal  tubular and glomerular cells 
from fetal and  adult  donors  by an  indirect  immunoperoxidase technique.  CALLA 
could also be detected on epithelial cells of the fetal small intestine and on myoepi- 
thelial cells of adult breast but not on myoepithelial cells of the salivary gland. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis of immunopre- 
cipitated  aesI-labeled membrane antigens  from dissociated  renal  cells demonstrated 
that the antigen migrated as a 90,000 mol wt antigen rather than the 98,000-100,000 
mol wt antigen  noted on CALLA-positive tissue culture cell lines. The data suggest 
that the determinant defined by the J-5 monoclonal antibody is neither a  lymphoid 
cell-specific differentiation antigen nor a leukemia-specific antigen. 
We thank Mr. William Boyarsky for the excellent  photographic work and Mr. Frank Tuck for 
technical assistance. 
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